Purchase Order 75N92020P00033

Award Date 12/9/19
Potential Completion Date 12/8/22
Potential Value $278K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
San Diego, CA 92122, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price purchase order contract awarded by the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), a component of the National Institutes of Health (NIH), to Illumina, Inc. for a Laboratory Information Management System (LIMS). The contract has a ceiling value of $371,720.00 and a period of performance ending on December 8, 2027. Illumina, a manufacturer of genomic sequencing and analysis instruments and reagents, has previously received prime and...
This contract is a firm fixed-price purchase order awarded by the National Institute of Environmental Health Sciences (NIEHS), a civilian agency under the U.S. Department of Health and Human Services, to Illumina, Inc., a for-profit manufacturer of genetic sequencing instruments and software. The $29,770 contract provides one year of support and maintenance services for Illumina's BaseSpace Clarity software, a laboratory information management system (LIMS) used for genomic research. The...
This is a firm fixed-price purchase order awarded by the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), a civilian agency, to Illumina, Inc., a for-profit organization and manufacturer of genetic sequencing and genomic analysis technologies. The $23,443.44 contract has an ultimate completion date of April 30, 2026 and does not utilize any set-aside designations. The contract provides for the procurement of Illumina's advanced sequencing instruments, reagents,...
This firm fixed-price delivery order was awarded by the National Heart Lung and Blood Institute (NHLBI), which is part of the National Institutes of Health (NIH), a civilian agency. The contract, valued at $110,254.47, is with Illumina, Inc., a manufacturer of genomic sequencing systems and consumables. Illumina has provided these products and associated services to support genomic research and analysis across various federal agencies in the past. This order does not include any set-aside...
This is a firm fixed price delivery order contract awarded by the Department of Health and Human Services' National Institutes of Health (NIH) National Institute of Arthritis and Musculoskeletal and Skin Diseases to Illumina, Inc., a for-profit manufacturer of genomic sequencing instruments and reagents. The $144,182.10 contract is to provide Illumina sequencing systems, reagents, and related products and services to support genomic research and analysis at the NIH. Illumina has a history of...
This is a firm fixed price purchase order for $25,000.00 awarded by the National Institute of Environmental Health Sciences, a civilian agency, to Illumina, Inc., a manufacturer of sequencing and genomic analysis equipment, for BASESPACE SOFTWARE LICENSES. The award has no set-aside designation. Illumina has previously received prime federal contracts and subcontracts from agencies like the NIH, CDC, USDA, and VA to provide sequencing systems, reagents, and other products to support genomic...
This is a $29,770 firm fixed price purchase order awarded by the National Institute of Environmental Health Sciences (NIEHS) to Illumina, Inc. for BaseSpace Clarity LIMS Gold Support and Maintenance services. The contract is for a one-year base period from July 15, 2024 to July 14, 2025. This is a sole source award as Illumina is the only responsible source for the required proprietary software and maintenance services. The Clarity software is used by NIEHS to run all next-generation DNA...
This is a firm fixed-price delivery order contract awarded by the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), a civilian agency under the National Institutes of Health (NIH), to Illumina, Inc. for $101,126.67. The contract is for the provision of Illumina's proprietary genomic sequencing systems, reagents, and related services to support NIAMS's research and diagnostic needs. Illumina has a history of providing similar products and services to other federal...
This is a firm fixed price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to Illumina, Inc. for $10,394.80. The award is for laboratory equipment and supplies, with no set-aside designation. Illumina, a manufacturer of genomic sequencing and analysis instruments and reagents, has provided a range of sequencing systems and supporting products to various federal agencies through past prime...
This firm fixed-price delivery order was awarded by the Department of Health and Human Services' National Institutes of Health (NIH) National Institute of Arthritis and Musculoskeletal and Skin Diseases to Illumina, Inc., a manufacturer of sequencing and genomic analysis instruments and reagents. The contract, valued at $110,962.23, is for the provision of sequencing systems, consumables, and related support services to support genomic research over a one-year period from September 2019 to...

This is a firm fixed price purchase order contract awarded by the Department of Health and Human Services, National Institutes of Health, National Heart Lung and Blood Institute to Illumina, Inc., a manufacturer of genomics analysis instruments and reagents. The contract is for a $277,908.00 annual subscription to the Illumina BaseSpace Clarity LIMS software to support the research efforts of the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) Intramural Research Program. The LIMS software provides end-to-end workflow tracking, integration with Illumina sequencing instruments, automation, and reporting functionality to manage the increasing demands of genomics research at NIAMS. There was no set-aside designation for this award. Illumina has previously received other federal contracts and sub-grants from agencies like the NIH, CDC, USDA, and VA to provide genomics sequencing instruments, reagents, and associated services.

Generated 3/22/24, 2:53 AM